L3VLUP
ProSign in

BEAM · AMGN in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

BEAMAMGN
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • BEAM
  • AMGN
0102030202120222023202420252026
Holders and value by quarter
QuarterBEAMAMGN
Q3 2020none listed holders, n.a.16 holders, $16.3bn
Q4 20204 holders, $705m19 holders, $14.0bn
Q1 20216 holders, $1.1bn16 holders, $14.5bn
Q2 20216 holders, $2.1bn23 holders, $13.8bn
Q3 20215 holders, $769m24 holders, $11.6bn
Q4 20213 holders, $818m21 holders, $10.4bn
Q1 20224 holders, $620m23 holders, $9.9bn
Q2 20224 holders, $457m28 holders, $9.7bn
Q3 20225 holders, $610m21 holders, $7.9bn
Q4 20224 holders, $481m24 holders, $9.3bn
Q1 20234 holders, $397m22 holders, $8.4bn
Q2 20233 holders, $394m26 holders, $7.4bn
Q3 20234 holders, $351m26 holders, $8.7bn
Q4 20234 holders, $389m24 holders, $8.4bn
Q1 20244 holders, $446m25 holders, $6.7bn
Q2 20243 holders, $379m20 holders, $8.0bn
Q3 20243 holders, $370m21 holders, $8.8bn
Q4 20244 holders, $394m20 holders, $8.2bn
Q1 20255 holders, $419m25 holders, $12.0bn
Q2 20255 holders, $358m20 holders, $10.2bn
Q3 20257 holders, $571m17 holders, $10.4bn
Q4 20256 holders, $692m19 holders, $18.0bn
Q1 20263 holders, $540m15 holders, $21.4bn
Q2 20263 holders, $713m23 holders, $24.9bn
BEAM

Beam Therapeutics Inc

Holders
4
Reported value
$446m
Buyers
2
Sellers
3

Breadth -1 among 93 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
AMGN

Amgen Inc

Holders
25
Reported value
$6.7bn
Buyers
10
Sellers
15

Breadth -5 among 93 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q1 2024

Among the 28 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only BEAM (3)

Baillie Gifford & Co, Farallon Capital Management LLC, PDT Partners LLC

Only AMGN (24)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Bridgewater Associates LP, Capital Research Global Investors, Caxton Associates LLP, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, Neuberger Berman Group LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Tudor Investment Corp, Two Sigma Advisers LP, Two Sigma Investments LP, Verition Fund Management LLC, Winton Group Ltd, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →